The SMR method identified a significant association between PCSK9 gene expression in whole blood and reduced IPF risk (OR = 0.71, 95% CI: 0.50–0.99, P = 0.043). The gene discussed is PCSK9; the disease is idiopathic pulmonary fibrosis.